Hypertension Clinical Trials

Showing 2921-2940 of 3,009 trials

Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension

NCT00693199

The aim of this study was to investigate the efficacy and safety of low dose amlodipine alone, or combined with low dose terazosin in male patients with both lower urinary tract symptoms and hypertension.

Lower Urinary Tract SymptomsHypertension

Anhui Medical University360 participantsStarted Jul 2006

Hefei, Anhui, China

COMPLETED

The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive Patients

NCT00728858

Nifedipine and barnidipine act as calcium channel blockers, and are widely prescribed for pressure control of prehypertension and stage 1 hypertension. CYP3A4 is responsible for the metabolism of nifedipine and nifedipine, while the contribution of CYP3A5 remains ambiguous. This study is aimed to analyze the association between antihypertensive effects of nifedipine as well as barnidipine and single nucleotide polymorphisms of CYP3A4, CYP3A5 and calcium channels.

Hypertension

National Taiwan University Hospital43 participantsStarted Apr 2006

COMPLETEDPhase 3

Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98

NCT00047593

The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after twelve months of treatment in Japanese subjects.

Open-Angle GlaucomaOcular Hypertension

Alcon ResearchStarted Jan 2000

Los Angeles, California, United States • San Francisco, California, United States • Honolulu, Hawaii, United States

COMPLETEDPhase 3

Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70

NCT00047541

To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.

Open-Angle GlaucomaOcular Hypertension

Alcon ResearchStarted Feb 2001

Fort Worth, Texas, United States

Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension

The Efficacy, Safety and Genetic Polymorphism of Hypoca and Adalat OROS in Hypertensive Patients

Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98

Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70

Related Searches

A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma

Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension

Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients

Atrial Fibrillation Incidence, Risk Factors and Genetics

Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)

Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)

Use of Sanvar® With Endoscopic Treatment for the Control of Acute Variceal Bleeding

Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension

Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months

Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy

Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.

Psychosocial Determinants of Medication Adherence in Hypertensive African Americans

Management of Patients With Type 2 Diabetes and Hypertension Using Mobile Health Care System

Intervention Study to Control High Blood Pressure for Korean American

Olmesartan in Essential Hypertension